GLP-1 & Metabolic
Retatrutide + Cagrilintide
Triple Agonist + Amylin Analog
Retatrutide co-formulated at a fixed 1:1 ratio with cagrilintide, a lipidated amylin analog, for dual-pathway (incretin plus amylin/calcitonin-receptor) in-vitro studies. Supplied in a single vial and tested as a finished blend.
- Amylin / calcitonin receptor
- GLP-1R / GIPR / GCGR agonism
- Dual-pathway assays
Supplied as lyophilized powder · Solvent not included · Lot-matched COA enclosed
$165
- Same-day dispatch on orders placed by 2 PM EST
- Free shipping on orders $200+
- Lot-matched COA included in every box
For in-vitro laboratory research use only. Not for human or veterinary use, or for diagnostic or therapeutic purposes. Sold to qualified laboratories and research organizations; by purchasing you confirm you are 21+ and ordering on behalf of a research organization.
Technical details
- Form
- Lyophilized powder, single vial
- Appearance
- White to off-white lyophilized powder
- Purity
- ≥99% by RP-HPLC (214 nm)
- Identity
- ESI-MS against theoretical mass, lot-matched
- Solubility
- Soluble in water; see COA for lot-specific notes
- Storage & Stability
- Lyophilized: −20 °C, protected from light and moisture. Solution stability: 30 days at 2–8 °C.
- Documentation
- Lot-matched COA in every order · SDS available on request
- Current lot
- Lot-matched COA ships with every order · look one up at /coa
The label on your vial
For in-vitro laboratory research use only. Not for human or veterinary use, or for diagnostic or therapeutic purposes. Supplied to qualified laboratories and research organizations. Nothing on this page describes effects in humans or animals.
- Independently verified by an accredited US analytical lab
- Sealed, light-protected vial with tamper-evident cap
- Insulated, plain outer packaging with COA enclosed
